The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Public ClinicalTrials.gov record NCT04075305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Study identification
- NCT ID
- NCT04075305
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 8,000 participants
Conditions and interventions
Conditions
- Oncology
- Breast Cancer
- Prostate Cancer
- Gynecologic Cancer
- Brain Tumor
- Brain Cancer
- Gynecologic Tumor
- Prostate Tumor
- Prostate Neoplasm
- Breast Tumor
- Radiation Toxicity
- Quality of Life
- Rectal Cancer
- Rectal Tumor
- Rectal Neoplasms
- Lung Cancer
- Lung Tumor
- Lung Neoplasm
- Esophageal Cancer
- Esophagus Cancer
- Esophageal Tumor
- Esophageal Neoplasm
- Esophagus Tumor
- Esophagus Neoplasm
- Pancreatic Cancer
- Pancreatic Tumor
- Pancreatic Neoplasms
- Head and Neck Cancer
- Head and Neck Neoplasms
- Head and Neck Tumor
- Tumor
- Neoplasms
- Bladder Cancer
- Bladder Neoplasm
- Liver Cancer
- Liver Neoplasms
- Liver Metastases
- Oligometastases
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2019
- Primary completion
- Jan 31, 2030
- Completion
- Jul 31, 2030
- Last update posted
- Mar 4, 2026
2019 – 2030
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| Md Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04075305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04075305 live on ClinicalTrials.gov.